The Latest Cardiac and Vascular News
FRANKLIN LAKES, N.J., July 9, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of TVA Medical, Inc., a company that develops minimally invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis. In the U.S. alone, there are more than 440,000 […]
Results from 236 patients across 28 sites in seven countries presented at LINC 2018 support growing body of evidence for pioneering clinical approach [01-February-2018] LEIPZIG, Germany, Feb. 1, 2018 /PRNewswire/ — An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for hemodialysis access was presented today at Leipzig Interventional […]
AUSTIN, Texas, Sept. 27, 2017 /PRNewswire/ — TVA Medical, Inc., a medical device company developing innovative therapies for end-stage renal disease (ESRD), today announced that its everlinQTM 4 endoAVF System has received CE Mark in the European Union. The technology uses a 4 French catheter system with enhanced visual indicators to create hemodialysis access using an endovascular technique without […]
AUSTIN, Texas, June 15, 2017/PRNewswire/ — TVA Medical, Inc. today announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQTM endoAVF System. The 12-month data published online in the American Journal of Kidney Diseases (AJKD), the official journal of the National Kidney Foundation, demonstrate the potential benefit of […]
